Finance

Lists
688513:SHA
Chengdu Easton Biopharmaceuticals Co Ltd
CN¥41.00
+0.79%
(+0.32) 1D
Nov 4, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688513...
Open
CN¥40.97
High
CN¥41.75
Low
CN¥38.71
Mkt. cap
7.18B
Avg. vol.
1.84M
Volume
3.43M
Dividend
1.20%
Quarterly dividend
CN¥0.12
Ex-dividend date
Jun 2, 2026
P/E ratio
25.93
52-wk high
CN¥80.48
52-wk low
CN¥38.71
EPS
CN¥1.58
No. of employees
1K
Open
CN¥40.97
High
CN¥41.75
Low
CN¥38.71
Mkt. cap
7.18B
Avg. vol.
1.84M
Volume
3.43M
Dividend
1.20%
Quarterly dividend
CN¥0.12
Ex-dividend date
Jun 2, 2026
P/E ratio
25.93
52-wk high
CN¥80.48
52-wk low
CN¥38.71
EPS
CN¥1.58
No. of employees
1K
News stories
From web sources and news partners
About Chengdu Easton Biopharmaceuticals Co Ltd
CEO-
Employees1.42K
FoundedJun 1, 2009
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteeastonpharma.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
312.26M
326.26M
332.64M
331.55M
Cost of goods sold
88.47M
73.62M
82.94M
75.99M
Cost of revenue
88.47M
73.62M
82.94M
75.99M
Research and development expenses
79.44M
72.66M
77.99M
83.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
128.80M
143.86M
107.14M
103.70M
Operating expense
214.09M
212.02M
195.99M
162.95M
Total operating expenses
302.56M
285.64M
278.93M
238.94M
Operating income
9.70M
40.62M
53.71M
92.61M
Other non operating income
230.85K
-519.09K
493.27K
52.00K
EBT including unusual items
57.56M
47.40M
86.84M
72.70M
EBT excluding unusual items
51.53M
41.48M
54.72M
95.38M
Income tax expense
4.15M
4.12M
18.02M
7.78M
Effective tax rate
7.21%
8.69%
20.75%
10.71%
Other operating expenses
8.00M
-4.46M
11.52M
-24.61M
Net income
63.90M
50.83M
78.92M
78.87M
Net profit margin
20.46%
15.58%
23.73%
23.79%
Earnings per share
-
-
-
-
Interest and investment income
42.65M
1.95M
2.46M
1.56M
Interest expense
-622.07K
-575.93K
-792.69K
-
Net interest expenses
42.02M
1.38M
1.67M
1.56M
Depreciation and amortization charges
-
-
-
-
EBITDA
32.44M
63.37M
81.43M
115.35M
Gain or loss from assets sale
-29.35K
-
-18.53K
18.53K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps